Oppenheimer Reiterates “Hold” Rating for Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries (NYSE:TEVA)‘s stock had its “hold” rating reaffirmed by equities researchers at Oppenheimer in a research note issued to investors on Thursday.
A number of other research analysts have also recently commented on TEVA. Citigroup cut Teva Pharmaceutical Industries from a “buy” rating to a “neutral” rating and lowered their target price for the company from $32.00 to $19.00 in a research note on Wednesday, August 16th. BidaskClub downgraded Teva Pharmaceutical Industries from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Mizuho restated a “neutral” rating and issued a $16.00 price objective (down from $30.00) on shares of Teva Pharmaceutical Industries in a research report on Tuesday, August 22nd. Credit Suisse Group downgraded Teva Pharmaceutical Industries from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $25.00 to $13.00 in a research report on Wednesday, August 23rd. Finally, TheStreet downgraded Teva Pharmaceutical Industries from a “c-” rating to a “d+” rating in a research report on Friday, August 25th. Seven equities research analysts have rated the stock with a sell rating, eighteen have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $19.34.
Teva Pharmaceutical Industries (NYSE:TEVA) traded down $0.82 during midday trading on Thursday, reaching $15.70. The company’s stock had a trading volume of 30,494,500 shares, compared to its average volume of 15,888,267. Teva Pharmaceutical Industries has a 1-year low of $10.85 and a 1-year high of $38.31. The company has a current ratio of 0.96, a quick ratio of 0.66 and a debt-to-equity ratio of 1.20. The stock has a market cap of $16,784.32, a PE ratio of 3.82 and a beta of 0.55.
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.
Receive News & Ratings for Teva Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.